Europe · General news · Sciences et Avenir

Cancer du pancréas : la percée du daraxonrasib

Published by Sciences et Avenir · France 15 h ago

Detailed summary

Un nouveau médicament, le daraxonrasib, a doublé la durée médiane de survie de patients atteints d’un cancer du pancréas métastatique. Une avancée majeure contre l’un des cancers…

Read the full article on Sciences et Avenir Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.sciencesetavenir.fr)

Also worth reading

Evening Standard

Wales beat New Zealand for first time since 1953 with historic victory

Daily Mail

Are these the drones that sparked US panic at RAF Lakenheath? Flashing lights seen near base days after America evacuated planes amid Iran threat

RTÉ

Bishop supports call for talks on declining birth rate

Daily Mirror

Water minister issues 'small habits' advice as severe droughts continue post-heatwaves

The Independent

Alaska elects its first Democrat governor in nearly 30 years in major blow to Trump

Metro